• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化纳米颗粒疫苗以增强抗原交叉呈递。

Engineering nanoparticulate vaccines for enhancing antigen cross-presentation.

机构信息

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610064, PR China.

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610064, PR China.

出版信息

Curr Opin Biotechnol. 2020 Dec;66:113-122. doi: 10.1016/j.copbio.2020.06.015. Epub 2020 Aug 1.

DOI:10.1016/j.copbio.2020.06.015
PMID:32745889
Abstract

Efficient cross-presentation is pivotal for vaccination against cancer and infection by intracellular virus and bacteria. Recently, various types of nanoparticle vaccines have been developed and investigated for efficiently and specifically improving cross-presentation and CD8 T cell priming. In this review, we will summarize the known intracellular pathways involved in cross-presentation, and focus on several nanoparticle strategies that have been reported for enhancing cross-presentation, including designing multifunctional nano-vaccines for increasing endosomal escape, designing nano-vaccines that can target lymph nodes to improve antigen uptake by lymph node resident CD8α dendritic cells, and co-delivering immune modulators for upregulating cross-presentation related intracellular components. We will also briefly discuss the future prospects of cross-presentation based nano-vaccine strategy for curing diseases.

摘要

有效的交叉呈递对于预防癌症和细胞内病毒和细菌感染的疫苗接种至关重要。最近,已经开发并研究了各种类型的纳米颗粒疫苗,以有效地和特异性地改善交叉呈递和 CD8 T 细胞的启动。在这篇综述中,我们将总结已知的涉及交叉呈递的细胞内途径,并重点介绍几种已报道的增强交叉呈递的纳米颗粒策略,包括设计多功能纳米疫苗以增加内体逃逸,设计能够靶向淋巴结以提高淋巴结驻留 CD8α 树突状细胞摄取抗原的纳米疫苗,以及共同递送免疫调节剂以上调与交叉呈递相关的细胞内成分。我们还将简要讨论基于纳米疫苗策略的交叉呈递治疗疾病的未来前景。

相似文献

1
Engineering nanoparticulate vaccines for enhancing antigen cross-presentation.工程化纳米颗粒疫苗以增强抗原交叉呈递。
Curr Opin Biotechnol. 2020 Dec;66:113-122. doi: 10.1016/j.copbio.2020.06.015. Epub 2020 Aug 1.
2
Bioinspired vaccines to enhance MHC class-I antigen cross-presentation.仿生疫苗增强 MHC Ⅰ类抗原交叉呈递。
Curr Opin Immunol. 2022 Aug;77:102215. doi: 10.1016/j.coi.2022.102215. Epub 2022 Jun 4.
3
Delivered antigen peptides to resident CD8α DCs in lymph node by micelle-based vaccine augment antigen-specific CD8 effector T cell response.胶束基疫苗将抗原肽递送至淋巴结中的驻留 CD8α DC,增强抗原特异性 CD8 效应 T 细胞应答。
Eur J Pharm Biopharm. 2020 Feb;147:76-86. doi: 10.1016/j.ejpb.2019.12.013. Epub 2019 Dec 28.
4
Enzyme-triggered antigen release enhances cross-presentation by dendritic cells.酶触发的抗原释放增强树突状细胞的交叉呈递。
Nanomedicine. 2022 Jun;42:102545. doi: 10.1016/j.nano.2022.102545. Epub 2022 Mar 11.
5
Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation.聚(丙硫醚)纳米粒子通过二硫键连接的肽向树突状细胞传递抗原:交叉呈递和 T 细胞激活。
Vaccine. 2010 Nov 23;28(50):7897-906. doi: 10.1016/j.vaccine.2010.09.077. Epub 2010 Oct 8.
6
Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.基于聚糖的树突状细胞特异性细胞间黏附分子-3 结合非黏附分子靶向疫苗增强抗原交叉呈递。
Mol Immunol. 2013 Sep;55(2):143-5. doi: 10.1016/j.molimm.2012.10.031. Epub 2012 Nov 14.
7
Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?佐剂增强树突状细胞的交叉呈递:更有效的疫苗的关键?
Front Immunol. 2018 Dec 13;9:2874. doi: 10.3389/fimmu.2018.02874. eCollection 2018.
8
Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.细胞内病原体感染期间脾脏CD8α⁺树突状细胞的独特功能。
Immunol Lett. 2007 Dec 15;114(2):66-72. doi: 10.1016/j.imlet.2007.09.007. Epub 2007 Oct 12.
9
Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.疫苗载体编码的腺病毒血清 5 型抗原,通过 CD8α+树突状细胞亚群,优先呈递给 CD8+T 淋巴细胞。
Vaccine. 2011 Aug 11;29(35):5892-903. doi: 10.1016/j.vaccine.2011.06.071. Epub 2011 Jul 1.
10
Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.Ⅰ 型干扰素控制摄取肿瘤凋亡细胞后 CD8α(+)树突状细胞的抗原保留和存活,从而导致交叉呈递。
J Immunol. 2011 May 1;186(9):5142-50. doi: 10.4049/jimmunol.1004163. Epub 2011 Mar 25.

引用本文的文献

1
Recent advances in the bench-to-bedside translation of cancer nanomedicines.癌症纳米药物从实验室到临床应用转化的最新进展。
Acta Pharm Sin B. 2025 Jan;15(1):97-122. doi: 10.1016/j.apsb.2024.12.007. Epub 2024 Dec 14.
2
CircRNA-loaded DC vaccine in combination with low-dose gemcitabine induced potent anti-tumor immunity in pancreatic cancer model.负载环状RNA的树突状细胞疫苗联合低剂量吉西他滨在胰腺癌模型中诱导了强大的抗肿瘤免疫力。
Cancer Immunol Immunother. 2025 Jan 3;74(2):68. doi: 10.1007/s00262-024-03924-x.
3
Tailoring biomaterials for vaccine delivery.
为疫苗传递量身定制生物材料。
J Nanobiotechnology. 2024 Aug 12;22(1):480. doi: 10.1186/s12951-024-02758-0.
4
Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions.纳米技术时代的癌症 mRNA 疫苗佐剂:策略、应用和未来方向。
J Nanobiotechnology. 2024 Jun 2;22(1):308. doi: 10.1186/s12951-024-02590-6.
5
Biomimetic and bioinspired nano-platforms for cancer vaccine development.用于癌症疫苗开发的仿生和受生物启发的纳米平台。
Exploration (Beijing). 2023 Apr 25;3(3):20210263. doi: 10.1002/EXP.20210263. eCollection 2023 Jun.
6
Dendritic cell-based vaccine prepared with recombinant enhances antigen cross-presentation and antitumor efficacy through ROS production.基于树突状细胞的疫苗用重组 制备,通过 ROS 产生增强抗原交叉呈递和抗肿瘤疗效。
Front Immunol. 2023 Aug 30;14:1208349. doi: 10.3389/fimmu.2023.1208349. eCollection 2023.
7
Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies.先进的亚单位疫苗递送技术:从疫苗级联障碍到设计策略
Acta Pharm Sin B. 2023 Aug;13(8):3321-3338. doi: 10.1016/j.apsb.2023.01.006. Epub 2023 Jan 10.
8
Current status of nano-vaccinology in veterinary medicine science.兽医学纳米疫苗学的现状。
Vet Med Sci. 2023 Sep;9(5):2294-2308. doi: 10.1002/vms3.1221. Epub 2023 Jul 24.
9
Vaccine adjuvants: mechanisms and platforms.疫苗佐剂:作用机制与平台。
Signal Transduct Target Ther. 2023 Jul 19;8(1):283. doi: 10.1038/s41392-023-01557-7.
10
Recent progress in application of nanovaccines for enhancing mucosal immune responses.纳米疫苗在增强黏膜免疫反应应用方面的最新进展。
Acta Pharm Sin B. 2023 Jun;13(6):2334-2345. doi: 10.1016/j.apsb.2022.08.010. Epub 2022 Aug 21.